Clinical trial
Evaluation of Patients With Immune Function Abnormalities
NCT00128973 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Recruiting
Key facts
| NCT number | NCT00128973 |
|---|---|
| Title | Evaluation of Patients With Immune Function Abnormalities |
| Official title | Screening and Baseline Assessment of Patients With Abnormalities of Immune Function |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Chronic Granulomatous Disease (CGD), X-Linked Severe Combined Immune Deficiency (XSCID), Leukocyte Adhesion Deficiency 1 (LAD), Graft Versus Host Disease (cGvHD) |
| Enrollment | 3,500 |
| Start date | Sep 19, 2005 |
| First posted | Aug 10, 2005 |
| Last update posted | Jan 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: